U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07218744) titled 'Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB123667 in Healthy Male Participants' on Oct. 16.
Brief Summary: This study will assess the mass balance, pharmacokinetics, and metabolite profiles of a single oral dose of [14C] INCB123667 in healthy male participants.
Study Start Date: Nov. 13
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: INCB123667
INCB123667 will be administered orally as a tablet dose, followed approximately 10 minutes later by an oral dose solution of radiolabeled INCB123667.
Recruitment Status: NOT_YET_RECRUITI...